Doximity (NASDAQ:DOCS) Receives Outperform Rating from Raymond James

Raymond James restated their outperform rating on shares of Doximity (NASDAQ:DOCS) in a research report sent to investors on Friday,Benzinga reports. They currently have a $65.00 price objective on the stock, up from their previous price objective of $37.00.

DOCS has been the subject of several other reports. Canaccord Genuity Group boosted their price target on Doximity from $37.00 to $40.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a report on Friday, August 9th. Robert W. Baird upped their price target on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Truist Financial reaffirmed a “hold” rating and set a $35.00 price target (up from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a report on Monday, August 19th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Doximity has a consensus rating of “Moderate Buy” and an average target price of $45.69.

Doximity Stock Up 5.2 %

Shares of DOCS stock opened at $61.25 on Friday. Doximity has a 12-month low of $22.96 and a 12-month high of $61.75. The company has a market capitalization of $11.37 billion, a PE ratio of 70.40, a price-to-earnings-growth ratio of 7.00 and a beta of 1.30. The firm has a 50 day moving average price of $42.04 and a two-hundred day moving average price of $33.44.

Institutional Trading of Doximity

Hedge funds have recently added to or reduced their stakes in the stock. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in Doximity during the 1st quarter worth approximately $416,000. Janney Montgomery Scott LLC increased its position in Doximity by 17.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 20,802 shares of the company’s stock valued at $560,000 after buying an additional 3,086 shares in the last quarter. GSA Capital Partners LLP raised its stake in Doximity by 40.1% during the 1st quarter. GSA Capital Partners LLP now owns 17,390 shares of the company’s stock worth $468,000 after buying an additional 4,981 shares during the period. Texas Permanent School Fund Corp grew its stake in Doximity by 4.9% in the first quarter. Texas Permanent School Fund Corp now owns 106,915 shares of the company’s stock valued at $2,877,000 after acquiring an additional 5,018 shares during the period. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of Doximity by 18.9% during the first quarter. Oppenheimer Asset Management Inc. now owns 15,320 shares of the company’s stock valued at $412,000 after acquiring an additional 2,432 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.